Computational biology is also referred to as bioinformatics; it makes use of algorithms based on biological data to establish relations between different biological systems. By creating sophisticated modeling and simulation models for pharmacodynamics and pharmacokinetics, several recent drug discovery and development projects have made use of computational biology with successful results.

1. Global Computational Biology Market to
Exhibit 21.30% CAGR 2012-2018 as
Companies Target Better Clinical Trial
Outcomes
A number of drug candidates failing in late-stage clinical trials has
brought to the fore the importance of computational biology; this will
help the global computational biology market reach a valuation of
US$2.9 bn by 2018, rising rapidly from its 2011 valuation of US$0.7 bn,
says Transparency Market Research.
In its report, titled ‘Computational Biology Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018’, the
market intelligence firm also states that the computational biology
market will expand at a 21.30% CAGR worldwide.
The high CAGR of the market can be attributed to the fact that several
big pharma players such as Sanofi, Roche, Novartis, and Pfizer have
made investments in computational biology systems for improved
clinical outcomes and many other companies are expected to follow suit.
The computational biology market deals with the use of biology and
computers for drug discovery and drug development. This is conducted
through modeling and simulation models for pharmacokinetics and
pharmacodynamics. Rise in late stage drug failure coupled with
contraction of innovative drugs has led to huge financial losses to the
biotech pharmaceutical companies. It has therefore become imperative
for pharmaceutical companies to invest in computational biology. In
2011, the global computational biology market was valued to be USD

2. 760.2 million and is expected to grow at a CAGR of 21.3% from 2012 to
2018.
Computational biology also helps to reduce extensive use of humans in
trials and is therefore useful for pediatric trials, trials on pregnant
women and orphan disease research. The drug discovery market
accounts to be the largest market for computational biology as its use at
this stage helps in reduction of drug failure in the subsequent phase i.e.
development phase.
Currently, there is a large market of contract service providers of
computational biology; nonetheless multinational pharmaceutical
companies are setting up their own computational biology centers to
fasten the process of drug discovery and development. Governments
across the globe are funding infrastructure and academic courses to
improve and increase the number of computational biologists.
Browse Full Research Report on Computational Biology Market:
http://www.transparencymarketresearch.com/computational-
biology.html
In this study, the global computational biology market is segmented on
the basis of applications, tools, and geography. Basis application, the
market is segmented into disease modelling and simulation
applications/computer aided drug design and cellular modeling and
simulation. The disease modelling and simulation applications/computer
aided drug design segment is further segmented into drug discovery and
drug development. The cellular modeling and simulation segment is sub-
segmented into computational proteomics, computational genomics,
pharmacogenomics, and others.
The findings of the report indicate that the growth of the drug discovery
segment will be the fastest in the computational biology market by
application, with a CAGR of over 25.0% through the report’s forecast

3. period. On the basis of tools, the computational biology market has been
divided into analysis software and services, database, and IT
infrastructure (hardware).
From the geographical standpoint, the global computational biology
market has been segmented into North America, Europe, Asia Pacific,
and Rest of the World. According to the TMR report, North America has
conventionally been the largest market for computational biology in the
world. While the region will maintain its lead in the near future,
aggressively growing countries such as India and China in the Asia
Pacific region will create a massive opportunity for growth for
companies in this market.
The study also comprises a comprehensive study of the competitive
landscape in the computational biology market. Companies studied in
the report include: Certara, Accelrys, Chemical Computing Group Inc.,
Entelos, Compugen, Ltd, Insilico Biotechnology AG, Genedata AG, and
others.
Browse Full Press Release on Computational Biology Market:
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants use
proprietary data sources and various tools and techniques to gather and
analyze information.
Press Release

4. TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research material
for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com